ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior Director, Biostatistics at Generate:Biomedicines - ApplyBlast

Senior Director, Biostatistics

Generate:Biomedicines

16 days ago

4.0 on Glassdoor

Somerville, Massachusetts, United States

Onsite

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Senior Director, Biostatistics leads statistical strategy and execution for late-stage development programs, ensuring regulatory readiness and scientific rigor. This role involves partnering with cross-functional teams to drive informed decision-making from early development through registration. The position requires hands-on leadership in statistical deliverables and team mentorship.

Responsibilities

Lead statistical strategy for late-stage clinical development programs
Draft and review statistical analysis plans and regulatory submissions
Mentor and develop a high-impact biostatistics team

Skills

Qualifications

PhD in Statistics/BiostatisticsMS in Statistics/Biostatistics

About Generate:Biomedicines

generatebiomedicines.com

Headquarters

Somerville, Massachusetts, United States

Company Size

201-500 employees

View Profile

Generate:Biomedicines is a therapeutics company that combines machine learning, computational biology, and biological engineering to design and develop precision protein medicines and antibodies. Using generative AI and lab-driven engineering, the company builds targeted biologics and epitope-focused candidates, advancing a pipeline from discovery through clinical development. Its clinical-stage programs include GB-0895, a long‑acting anti‑TSLP antibody progressing to global Phase 3 studies, and the company has recently completed an initial public offering. Generate was incubated by Flagship Pioneering and emphasizes platform-driven discovery to accelerate novel biologic therapeutics.